Ligand validation:4RJK

PYR: PYRUVIC ACID

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4RJK_PYR_G_608	78%	9%	0.108	0.956	2.95	1.52	3	1	0	0	100%	1
4RJK_PYR_G_607	30%	7%	0.239	0.912	2.91	1.84	3	2	0	0	100%	1
4RJK_PYR_F_610	16%	8%	0.3	0.881	2.92	1.6	3	1	0	0	100%	1
4RJK_PYR_H_605	10%	10%	0.388	0.916	3	1.27	3	-	0	0	100%	1
4RJK_PYR_F_609	2%	6%	0.399	0.713	2.86	2.18	3	2	0	0	100%	1
2O9A_PYR_C_907	99%	2%	0.038	0.982	4.39	2.62	2	2	0	0	100%	1
4RV5_PYR_B_501	98%	16%	0.052	0.982	2.44	1.18	3	-	0	0	100%	1
5CM6_PYR_A_401	97%	10%	0.059	0.985	2.5	1.7	3	1	0	0	100%	1
3R75_PYR_B_702	97%	28%	0.062	0.987	1.5	1.32	1	1	0	0	100%	1
1WA3_PYR_A_1204	97%	20%	0.061	0.984	2.06	1.26	1	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729. RCSB PDB uses resources of the National Energy Research Scientific Computing Center (NERSC), a Department of Energy User Facility.